Physician profile
Leera Patel
NPI 1619932803
$33,791.77
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $15.42 · 2021: $125.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $32,482.38 | 2019 | |
| Novo Nordisk INC | $198.26 | 2019-2021 | |
| Shire North American Group INC | $182.71 | 2019 | |
| Sanofi-Aventis U.S. LLC | $164.55 | 2019 | |
| Abbvie INC. | $154.72 | 2019 | |
| Amgen INC. | $120.83 | 2019 | |
| Corcept Therapeutics | $79.63 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.58 | 2019 | |
| Merck Sharp & Dohme LLC | $64.48 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.65 | 2019 | |
| Dexcom, INC. | $45.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $43.77 | 2019 | |
| Insulet Corporation | $30.78 | 2019-2020 | |
| Amarin Pharma, INC. | $25.99 | 2019 | |
| Abbott Laboratories | $17.40 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $17.37 | 2019 | |
| Mannkind Corporation | $14.32 | 2019 | |
| Ibsa Pharma INC. | $14.14 | 2019 | |
| Senseonics, Incorporated | $13.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leera Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.